News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
JCOOA is open for submissions – American Society of Clinical Oncology
ASCO/LinkedIn
Oct 16, 2024, 14:37

JCOOA is open for submissions – American Society of Clinical Oncology

American Society of Clinical Oncology shared a post on X:

“JCOOA is open for submissions!

Open-access, interdisciplinary & unique content like Brief Reports, plain language summaries, and therapeutic and supportive care articles.

Submit research now.”

American Society of Clinical Oncology ASCO cancer cancer awareness cancer care fight against cancer Global fight against cancer JCOOA OncoDaily Oncology
Special Coverage
Blog
Jan 29, 2025, 22:39
Join SIOP for 'Radiotherapy for Rhabdomyosarcoma' on Paediatric Radiation Oncology Series
Blog
Jan 29, 2025, 22:27
Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer
Blog
Jan 29, 2025, 22:27
CtDNA in CRC Surveillance - Ready for Prime Time?
Insight
Jan 29, 2025, 22:27
The causes and consequences of clonal hematopoiesis after stem cell transplantation
Blog
Jan 29, 2025, 22:26
Julie S. Torode: Discussing new data to support advocacy on access to quality radiotherapy in Africa
Blog
Jan 29, 2025, 22:26
Denis Horgan: Precision Oncology - A Global Perspective on Implementation and Policy Development
Blog
Jan 29, 2025, 22:26
Monica Bertagnolli: Confident and healthy because of the results of many decades of NIH-funded research
Blog
Jan 29, 2025, 22:26
Mandi Pratt-Chapman: GW Oncology Patient Navigation - The Fundamentals Update
Blog
Jan 29, 2025, 22:26
Egyptian Society Of Breast Imaging - Highlights from BGICC2025
Blog
Jan 29, 2025, 22:26
Integrative Oncology Working Group - The Power of Words: Using Language as a Therapeutic Tool
Blog
Jan 29, 2025, 22:14
Yüksel Ürün: The impact of comorbidities on survival in cancer patients receiving ICIs
Blog
Jan 29, 2025, 22:05
Preliminary Safety, Antitumor Activity, and ctDNA Changes with Zoldonrasib in KRAS G12D PDAC